We will not keep your email address; we ask for it so your friend knows the email isn't spam.

You need to be signed in to access email alerts. If you have an account log in with your user name and password. If you don't have an account you can just enter your ...

1 μm-thick sections of superficial peroneal nerve biopsy specimens of two insulin-dependent diabetic patients in their 30s with a severe length-dependent diabetic polyneuropathy. (A) This patient ...

“Without treatment, ATTR-PN can lead to extreme polyneuropathy, severe disability, and premature death. In the NEURO-TTRansform Phase III clinical trial, eplontersen significantly lowered serum ...

Polyneuropathy is a rare but possible manifestation of severe hyperthyroidism. The patient reported here developed a polyneuropathy affecting mostly leg muscles (Basedow's paraplegia) during the ...

A drug in advanced development for myasthenia gravis also showed promise as a treatment for primary Sjögren's syndrome, a ...

Bexion Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing a novel class of biologic therapy to ...

Ania Turska is going through 'intensive' therapy to regain her ability to walk and talk, after being placed in a medically ...

Your nervous system is a key force behind so many important bodily functions. But when your peripheral nerves—those found outside of the brain and spinal cord—are damaged, it can cause pain and ...

An Edinburgh woman is going through 'intensive' therapy to regain her ability to walk and talk, after being placed in a ...

Analysts appear optimistic for Intellia’s gene editor nex-z, which showed a greater serum TTR reduction than Alnylam’s ...

Intellia's Phase 3 trial for NTLA-2002 shows promise, but limitations warrant caution. See why we believe NTLA stock is hold ...